公司资料
Novartis AG 股价、新闻与催化剂
- 股票代码:
- NVS
- 交易所:
- NYSE
- 行业:
- Biopharma, Novel Therapies, Gene Therapy
- 所在地:
- Switzerland
股票表现
151.97 USD (+0.72%)
收盘价
最后更新: 2026年8月17日
274B USD
市值
股价为何变动
As of Aug 17, 2026, NVS closed up 0.72% at $151.97. No new same-company headline was identified in the current news window.
公司概览
业务概览
Novartis is a global medicines company with major exposure to innovative therapies across oncology, immunology, neuroscience, and cardiovascular disease. The company has been reshaping its portfolio around higher-growth, innovation-driven products.
所在地与行业分类
Headquartered in Switzerland and listed on NYSE as an ADR, Novartis is a global biopharma with strong European and U.S. exposure. Its profile is defined by global commercial scale and a high-quality pipeline.
商业模式特征
Novartis generates value through branded medicines, launches, and pipeline reinvestment. Investors follow earnings quality, launch cadence, and whether the company can continue replacing mature products with growth assets.
生物医药行业定位
Novartis sits among the most important global pharma names because it combines scale with consistent innovation. It is less volatile than clinical-stage biotech, but pipeline and regulatory updates can still shift the story.
未来催化剂
- Novartis should be tracked for Fabhalta expansion, remibrutinib progress, and any late-stage update that keeps the growth mix shifting away from older franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。